M., Elmowafy M., Shalaby K., Zafar A., Abdelgawad M
The report notes the presence of counterfeit Ozempic, the use of non-FDA-approved ingredients such as retatrutide or cagrilintide, and products bypassing regulations by being labeled as not for human consumption. As of July 2024 the most recently issued report the FDA had received over 1,000 reports of adverse events related to compounded semaglutide and compounded tirzepatide
Fill up on fruits, vegetables, and whole grains On GLP-1s, volume isn't the goal nutrient density is Don't get us wrong, fruits and vegetables are great
To maintain freshness, refrigeration is required after opening the bottle
Many manufacturers market these products as supporting the bodys natural melanin production